Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
carboplatin (paraplatin) (1 trial)
gedatolisib (1 trial)
inotuzumab ozogamicin (besponsa) (1 trial)
paclitaxel (taxol) (1 trial)
temsirolimus (torisel) (1 trial)
Endometrial Neoplasms (Phase 1)
Lymphoma (Phase 1)
Ovarian Neoplasms (Phase 1)
Small Cell Lung Carcinoma (Phase 1)
Trials (2 total)
Trial APIs (5 total)